ÂÜÀòÂÒÂ×

Bhagat Singh is an accomplished professional with extensive experience in global program management and neuroscience. Currently serving as Senior Director of Global Program Management in the Orexin Franchise at Takeda since August 2019, Bhagat has previously held roles as Director and Associate Director in Global CNS Program and Portfolio Management. Prior experience includes serving as an Associate Consultant at ZS, managing alliances for the Harvard Stem Cell Institute, and collaborative projects at Harvard University. Academic credentials include a PhD in Neuroscience from the University of Calgary, a Mini MBA from Harvard Business School, and a Master's in Pharmacology, all complemented by a Bachelor’s degree in Pharmaceutical Sciences. Bhagat's research expertise encompasses neurobiology, pharmacology, and the development of therapeutics, with notable contributions to IND-enabling studies and a strong publication record.